• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Polaryx Therapeutics, Inc. - Common Stock (NQ:PLYX)

1.730 -0.020 (-1.14%)
Delayed Quote Updated: 12:53 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,766
Open 1.725
Bid (Size) 1.690 (200)
Ask (Size) 1.760 (100)
Prev. Close 1.750
Today's Range 1.690 - 1.780
52wk Range 1.720 - 48.91
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
September 01, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
August 25, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 96.5% below 52-week high
1.730
1.7252W Low 48.9152W High
1 Week 9.4% below 1-week high
1.721W Low 1.911W High

Polaryx Therapeutics, Inc. - Common Stock (PLYX) traded between $1.72 and $48.91 over the past 52 weeks and last traded at $1.73, 96.5% below its 52-week high. Over the past week it ranged between $1.72 and $1.91.

Past 12 Months
-8.0%
-16.4%
-21.0%
-66.2%
-95.1%
-95.1%
1W -$0.15
1M -$0.34
3M -$0.46
6M -$3.39
YTD -$33.27
1Y -$33.27

PLYX was -95.1% over the past year, -66.2% over six months, -95.1% year to date, -8.0% in the last week.

12 Months vs Market
PLYX
-95.1%
DIA
+9.5%
SPY
+10.8%
QQQ
+8.9%
IWM
+14.7%

Over the past 12 months PLYX returned -95.1% versus DIA (Dow) +9.5%, SPY (S&P 500) +10.8%, QQQ (Nasdaq 100) +8.9% and IWM (Russell 2000) +14.7%.

Volume & Liquidity 0.25× 3-mo avg
Today 13,766 3-mo avg 55.7K
1W
21.6K
1M
27.8K
3M
55.7K
6M
130.4K
YTD
680.4K
1Y
680.4K

PLYX most recently traded 13,766 shares against a 3-month average daily volume of 55.7K.

More News

Read More
News headline image
Why Polaryx Therapeutics Stock Is Surging On Thursday? ↗
May 28, 2026
Via Benzinga
News headline image
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
Tuesday's session: top gainers and losers ↗
May 26, 2026
Via Chartmill
Top stock movements in today's session. ↗
May 26, 2026
Via Chartmill
News headline image
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
May 14, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
April 23, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
April 21, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care
April 15, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference
April 01, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
March 17, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events
March 12, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? ↗
March 11, 2026
Via Stocktwits
Topics ETFs
News headline image
Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders
February 27, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
What's Going On With Polaryx Therapeutics Stock Wednesday? ↗
February 18, 2026
Via Benzinga
News headline image
Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans ↗
February 17, 2026
Via Benzinga
News headline image
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
February 17, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
February 10, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx Therapeutics Welcomes New Members of the Board of Directors
February 05, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire
News headline image
Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch
February 03, 2026
From Polaryx Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Polaryx Therapeutics, Inc. - Common Stock publicly traded?
Yes, Polaryx Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Polaryx Therapeutics, Inc. - Common Stock trade on?
Polaryx Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Polaryx Therapeutics, Inc. - Common Stock?
The ticker symbol for Polaryx Therapeutics, Inc. - Common Stock is PLYX on the Nasdaq Stock Market
What is the current price of Polaryx Therapeutics, Inc. - Common Stock?
The current price of Polaryx Therapeutics, Inc. - Common Stock is 1.730
When was Polaryx Therapeutics, Inc. - Common Stock last traded?
The last trade of Polaryx Therapeutics, Inc. - Common Stock was at 11/03/26 12:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap